Is there a genetic basis for pediatric stroke?

Current Opinion in Pediatrics

Volumn 15, Issue 6, 2003, Pages 547-558

  Kirkham, Fenella J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anemia; Cerebrovascular disorders; Child; Sickle cell; Stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HLA ANTIGEN; NITRIC OXIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; VASCULAR CELL ADHESION MOLECULE 1;

ARTERIOGRAPHY; ARTERY DISSECTION; BLOOD PRESSURE; CEREBRAL SINUS THROMBOSIS; CEREBROVASCULAR DISEASE; CHROMOSOME 17; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER FLOWMETER; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; HEADACHE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; HYPOXEMIA; HYPOXIA; IMAGING; IMMUNE DEFICIENCY; INFECTION; INFLAMMATION; INTERNAL CAROTID ARTERY; METHODOLOGY; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; OPTIC NERVE GLIOMA; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PHLEBOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEIZURE; SICKLE CELL ANEMIA; SINUS VENOSUS; STROKE; SYMPTOMATOLOGY;

ANEMIA, SICKLE CELL; BLOOD COAGULATION DISORDERS, INHERITED; CEREBROVASCULAR ACCIDENT; CHILD; DISSECTION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFECTION; LIPID METABOLISM; MOYAMOYA DISEASE; PHENOTYPE; SINUS THROMBOSIS, INTRACRANIAL;

EID: 0344676391     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200312000-00002     Document Type: Review

References (89)

1. World Health Organization: Cerebrovascular Disorders: A Clinical and Research Classification. Offset publication no. 43. Geneva: World Health Organization; 1978.
2. Jerrard-Dunne P, Cloud G, Hassan A, et al.: Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003, 34:1364-1369. In adults, particularly those younger than 65 years, family history of stroke is associated with large and small vessel disease rather than with cardioembolism or stroke of undetermined etiology.
3. Wraige E, Hajat C, Jan W, et al.: Ischaemic stroke subtypes in children and adults. Dev Med Child Neurol 2003, 45:229-232. The majority of children were classified within the "other determined etiology" subtype of the Trial of Org 10172 in Acute Stroke Therapy classification, whereas most adults had large or small vessel disease or cardioembolism.
4. Eriksson M, Brown WT, Gordon LB, et al. Recurrent de novo point mutations in lamina cause Hutchinson-Gilford progeria syndrome. Nature 2003, 423:293-298.
5. Barker DJ, Lackland DT: Prenatal influences on stroke mortality in England and Wales. Stroke 2003, 34:1598-1602.
6. Lynch JK, Hirtz DG, DeVeber GA, et al.: Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 2002, 109:116-123.
7. Fullerton HJ, Wu YW, Zhao S, et al.: Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189-194. This large epidemiologic study reports discharge coding for CaHornian children with ischemic stroke (annual incidence, 1.2/100,000), intracerebral hemorrhage (annual incidence, 0.8/100,000), and subarachnoid hemorrhage (annual incidence, 0.4/100,000). Stroke was more common in boys and in blacks (RR, 2.59; 95% CI, 2.17 to 3.09), but was less common in Hispanics.
8. Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167-173. This was a single-center cohort study with a detailed investigation of 212 consecutive children of all ethnicities, including 35 with sickle cell disease. Vascular imaging was performed in 87%, of whom 79% were abnormal. Hypertension was associated with vascular abnormality. Patent foramen ovale and thrombophilia were rare, but anemia and hyperhomocysteinemia were relatively common.
9. deVeber Q, Andrew M, Canadian Pediatric Ischemic Stroke Study Group: Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 9:417-423.
10. Mercuri E, Cowan F, Gupte G, et al.: Prothrombic disorders and abnormal neurodevelopmental outcome in infants with neonatal cerebral infarction. Pediatrics 2001, 107:1400-1404.
11. Sträter R, Becker S, von Eckardstein A, et al.: Prospective evaluation of risk factors for recurrent stroke during childhood-results of the 5-year follow-up. Lancet 2002, 360:1540-1545. This is an evaluation of the effect of prothrombic and other laboratory risk factors on the risk of recurrent infarction in the German collaborative cohort of white children. The recurrence risk was 6.6% overall over a median follow-up period of 44 months and was significantly increased in patients with familial protein C deficiency and in those with high lipoprotein (a) levels. Those with a vascular etiology also had a higher recurrence risk, although many symptomatic patients (eg, those with cardiac disease) did not undergo vascular imaging.
12. Ganesan V, Prengler M, Wade AM, et al.: Risk factors for recurrence of arterial ischemic stroke in childhood [abstract]. Stroke 2004, in press. Of a cohort of 212 consecutive patients with arterial ischemic stroke, 30 had recurrent stroke and 48 had recurrent transient ischemic attack over a follow-up period of 1 day to 21 years (median, 2.2 years). Prior diagnosis and moyamoya syndrome were associated significantly with clinical recurrence in the whole group. Genetic thrombophilia was associated significantly with clinical recurrence in previously healthy children. Sixty of 179 patients undergoing reimaging had radiologic reinfarction.
13. Husson B, Rodesch G, Lasjaunias P, et al.: Magnetic resonance angiography in childhood arterial brain infarcts: a comparative study with contrast angiography. Stroke 2002, 33:1280-1285. This comparison of conventional angiography and MR angiography in 24 patients studied acutely showed MR angiography was a good screening test, although distal disease and the degree of stenosis were better shown with conventional angiography. Vascular imaging will be very important for defining the phenotype in genetic studies.
14. Lanthier S, Lortie A, Michaud J, et al.: Isolated angiitis of the CNS in children. Neurology 2001, 56:837-842.
15. Dobson SR, Holden KR, Nietert PJ, et al.: Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002, 99:3144-3150. Of 44 patients younger than 18 years of age transfused regularly to a hemoglobin S of less than 30% for stroke in the context of sickle cell disease, 18 (44%) had recurrent stroke or transient ischemic attacks. Recurrence was best predicted by the presence of moyamoya collaterals on MR angiography or conventional angiography.
16. Hsia T-Y, Kirkham F, Waldman A, et al.: The implications of extensive cerebral vascular dysplasia in surgical repair of coarctation of the aorta and ventricular septal defect. J Thorac Cardiovasc Surg 2001, 121: 998-1001.
17. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.: Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 1998, 91:288-294.
18. Adams GT, Snieder H, McKie V, et al. Genetic risk factors for cerebrovascular disease in children with sickle cell disease: design of a case control association study and genomewide screen. BioMed Central BMC Medical Genetics 4:6, Online publication. This study presents a protocol for studying the genetic basis of transcranial Doppler velocities more than 200 cm/second in patients screened for the controlled trials of prophylactic blood transfusion, STOP, and STOP2.
19. Driscoll MC, Hurlet A, Styles L, et al.: Stroke risk in siblings with sickle cell anemia. Blood 2003, 101:2401-2404. This large multicenter study showed that for hemoglobin SS, the risk of stroke in siblings was greater than expected by chance, suggesting a familial predisposition. Further studies are needed to determine whether environmental or genetic factors are involved.
20. Kwiatkowski JL, Hunter JV, Smith-Whitley K, et al.: Transcranial Doppler ultrasonography in siblings with sickle cell disease. Br J Haematol 2003, 12:932-937. Normal and abnormal transcranial Doppler velocities were correlated within families, suggesting a familial predisposition to cerebrovascular disease in sickle cell disease.
21. Lee KH, McKie VC, Sekul EA, et al.: Unusual encephalopathy after acute chest syndrome: acute necrotizing encephalitis. J Pediatr Hematol Oncol 2002, 24:585-588. Two patients with depression of consciousness and focal signs in the context of acute chest syndrome had MR images that showed abnormal signal in the thalami bilaterally with additional changes in the cortex and brainstem despite normal MR angiography and venography. The possibility of an infectious encephalitis (eg, secondary to Mycoplasma) is discussed.
22. Coley SC, Porter DA, Calamante F, et al.: Quantitative MR diffusion mapping and cyclosporine-induced neurotoxicity. AJNR Am J Neuroradiol 1999, 20:1507-1510.
23. Henderson JN, Noetzel MJ, McKinstry RC, et al.: Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with acute chest syndrome in sickle cell disease. Blood 2003, 101:415-419. This is a prospective study of neurologic, cognitive, and MRI sequelae of all children requiring ventilation and erythrocytapheresis for acute chest syndrome in a single center. Some combination of seizures, silent infarction, cerebral hemorrhage, and reversible posterior leukoencephalopathy occurred in all five patients. The roles of hypoxemia, positive fluid balance leading to hypertension, abnormal autoregulation, and erythrocytapheresis are discussed.
24. van Mierlo TD, van den Berg HM, Nievelstein RAJ, et al.: An unconscious girl with sickle cell disease. Lancet 2003, 361:136. This is a case report of a child with sickle cell disease and obliteration of the straight, transverse and sigmoid sinuses, and partial obliteration of the sagittal sinus.
25. Sébire G, Tabarki B, Saunders DE, et al.: Venous sinus thrombosis in children [abstract]. Eur J Paediatr Neurol 2003, 7:263. Anemia (iron deficiency, sickle cell disease, thalassemia, hemolysis) was nearly as common an association with sinovenous thrombosis as prothrombic disorder in this multicenter study.
26. Pegelow CH, Macklin EA, Moser FG, et al.: Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002, 99:3014-3018. Children with silent infarction on initial MRI were more likely to have a clinical stroke and further silent infarction than those with normal scans at baseline.
27. Thompson R, Armstrong D, Link C, et al.: A prospective study of the relationship over time of behaviour problems, intellectual functioning, and family functioning in children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr Psychol 2003, 28:59-65. Follow-up of the Cooperative Study of Sickle Cell Disease cohort suggested that family conflict was a better predictor of behavioral problems than silent infarction.
28. Kinney TR, Sleeper LA, Wang WC: Silent cerebral infarcts in sickle cell anemia: a risk factor analysis. Pediatrics 1999, 103:640-645.
29. Wierenga KJJ, Serjeant BE, Serjeant GR: Cerebrovascular complications and parvovirus infection in homozygous sickle cell disease. J Pediatr 2001, 139:438-442.
30. 6 in pediatric patients with sickle cell disease. Am J Hematol 2002, 69:239-246. The optimal doses of folic acid and vitamins B12 and B6 were found by titrating escalating doses against homocysteine level.
31. Kirkham FJ, Hewes DK, Hargrave D, et al.: Nocturnal hypoxaemia predicts CNS events in sickle cell disease. Lancet 2001, 357:1656-1659.
32. O- thalassemia, only one (3%) had silent infarction, which is much lower than the prevalence of approximately 20% in North America. This article speculates on the role of high hemoglobin F levels, although better nutrition in this relatively rich country may also play a role.
33. Marouf R, Gupta R, Haider MZ, et al.: Silent brain infarcts in adult Kuwaiti sickle cell disease patients. Am J Hematol 2003, 73:240-243.
34. - thalassemia had silent infarction, none had velocities more than 126 cm/second, and only one had an IQ less than 85.
35. Hsu LL, Miller ST, Wright E.: Alpha thalassemia is associated with decreased risk of abnormal transcranial Doppler ultrasonography in children with sickle cell anemia. J Pediatr Hematol Oncol 2003, 25:622-628 α-Thalassemia-2 (α-/α-) prevalence was lower in children with velocities more than 200 cm/second compared with those with velocities less than 170 cm/second, screened with transcranial Doppler as part of the STOP trial.
36. Reiter CD, Wang X, Tanus Santos J, et al.: Cell-free haemoglobin limits nitric oxide bioavailabilty in sickle cell disease. Nat Med 2002, 8:1383-1389 Plasma from patients with sickle cell disease, a hemolytic anemia, contains cell-free ferrous hemoglobin, which reduces NO bioavailability and limits increases in forearm blood flow to NO donor infusions. This endothelial dysfunction may be an important mechanism in the development of vasculopathy.
37. Inati A, Taher A, Bou Alawi W, et al.: Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol 2003, 70:79-83. All β-globin haplotypes were found in Lebanon, with a predominance of Benin, but in contrast to previous studies, clinical severity was worse in those with high hemoglobin F (mainly those with the CAR haplotype).
38. Heller C, Heinecke A, Junker R, et al.: Cerebral venous thrombosis in children - a multifactorial etiology. Circulation 2003, 108:1362-1367. A prothrombic disorder was more common in children with sinovenous thrombosis than in control subjects. Only the combination of prothrombic disorder with a trigger, high lipoprotein (a) and protein C deficiency, were independently associated.
39. 1-antitrypsin deficiency in the eight patients tested.
40. Chabrier S, Lasjaunias P, Husson B, et al.: Ischaemic stroke from dissection of the craniocervical arteries in childhood: report of 12 patients. Eur J Paediatr Neurol 2003, 7:39-42. Of 59 consecutive children with arterial stroke who underwent conventional arteriography in a single center, five had extracranial and seven had intracranial dissection.
41. Gatenby P, Tucko R, Andrews C, et al.: Antiphospholipid antibodies and stroke in Down syndrome. Lupus 2003, 12:58-62. Two patients with Down syndrome and antiphospholipid syndrome, one of whom had moyamoya are presented. The controversial role of the antiphospholipid syndrome in the etiology of stroke in Down syndrome is discussed.
42. Gururaj A, Hardy D, Al-Gazali LI, et al.: Are the strokes in moyamoya syndrome associated with Down syndrome due to protein C deficiency? Brain Dev 2002, 24:719-722.
43. Connor SE, Hewes D, Ball C, et al.: Alagille syndrome associated with angiographic moyamoya. Childs Nerv Syst 2002, 18:186-190. A patient with Alagille syndrome and seizures is presented in whom vascular imaging revealed moyamoya.
44. Piccoli DA, Spinner NB: Alagille syndrome and the Jagged1 gene. Semin Liver Dis 2001, 21:525-534.
45. Bonduel M, Hepner M, Sciuccati G, et al.: Prothrombic disorders in children with moyamoya syndrome. Stroke 2001, 32:1786-1792.
46. Ikeda H, Sasaki T, Yoshimoto T, et al.: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999, 64:533-537.
47. Zafeiriou DI, Ikeda H, Anastasiou A, et al.: Familial moyamoya disease in a Greek family. Brain Dev 2003, 25:288-290. This family study in two Greek siblings with moyamoya showed linkage to 3p24-26, as demonstrated in Japanese familial moyamoya.
48. Yamauchi T, Tada M, Houkin K, et al.: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000, 31:930.
49. Inoue TK, Ikezaki K, Sasazuki T, et al.: Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000, 15:179-182.
50. Tang DC, Prauner R, Liu W, et al.: Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. Am J Hematol 2001, 68:164-169.
51. Cardo E, Campistol J, Vilaseca A, et al.: Stroke in infancy in a child with homocysteinuria. Dev Med Child Neurol 1999, 41:132-135.
52. Kelly PJ, Furie KL, Kistler JP: Stroke in young patients with hyperhomocysteinemia due to cystathionine beta-synthase deficiency. Neurology 2003, 60:275-279. Previously asymptomatic adults heterozygous for cystathionine β-synthase deficiency may present with stroke from a variety of mechanisms, including dissection, cardiac embolus, as well as premature atherosclerosis. It is very likely that heterozygosity for classic homocysteinuria presents as stroke in children as well, justifying screening with plasma homocysteine levels.
53. van Beynum IM, Smeitink JA, den Heijer M, et al.: Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation 1999, 99:2070-2072.
54. Prengler M, Sturt N, Krywawych S, et al.: The homozygous thermolabile variant of the methytenetetrahydrofolate reductase gene: a risk factor for recurrent stroke in childhood. Dev Med Child Neurol 2001, 43:220-225.
55. McColl MD, Chalmers EA, Thomas A, et al.: Factor V Leiden, prothrombin 20210G→A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999, 81:690-694.
56. Nowak-Göttl U, Sträter R, Heinecke A, et al.: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of ischemic stroke in childhood. Blood 1999, 94:3678-3682.
57. Cardo E, Monrós E, Colomé C, et al.: 677C→T Polymorphism of the 5,10 methylenetetrahydrofolate reductase gene, mid hyperhomocysteinemia, and vitamin status in children with stroke. J Child Neurol 2000, 15:295-298.
58. Kenet G, Sadetzki S, Murad H, et al.: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000, 31:1283-1288.
59. Barreirinho S, Ferro A, Santos M, et al.: Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol 2003, 28:134-138. In this Portuguese study, factor V Leiden and prothrombin G20210A appeared to be more common in children with stroke than in control subjects.
60. Akar N, Akar E, Ozel D, et al.: Common mutations at the homocysteine metabolism pathway and pediatric stroke. Thromb Res 2001, 102:115-120.
61. Houston PE, Rana S, Sekhsaria S, et al.: Homocysteine in sickle cell disease: relationship to stroke. Am J Med 1997, 103:192-196.
62. Balasa VV, Gruppo RA, Gartside PS, et al.: Correlation of the C677T MTHFR genotype with homocysteine levels in children with sickle cell disease. J Pediatr Hematol Oncol 1999; 21:397-400.
63. Balasa VV, Kalinyak KA, Bean JA, et al.: Hyperhomocysteinemia is associated with low plasma pyridoxine levels in children with sickle cell disease. J Pediatr Hematol Oncol 2002, 24:374-379. Hyperhomocysteinemia, either fasting or after a methionine load, was more common in children with sickle cell disease (38%) than in African-American control subjects (7%), and was related to low pyridoxine and folate levels.
64. Nelson MC, Zemel BS, Kawchak DA, et al.: Vitamin B6 status of children with sickle cell disease. J Pediatr Hematol Oncol 2002, 24:463-469. Seventy-seven percent of children with sickle cell disease age 3 to 20 years had plasma pyridoxine levels below the range for deficiency. Levels were related to general nutritional status (weight, body mass index, and arm circumference).
65. Kelly PJ, Shih VE, Kistler JP, et al.: Low vitamin B6 but not homocysteine is associated with increased risk of stoke and transient ischemic attack in the era of folic acid grain fortification. Stroke 2003, 34:51-54. In a case-control study of adults with stroke and transient ischemic attack, homocysteine levels were not higher in the patients, but pyridoxine levels were lower and the effect remained after adjustment for homocysteine level, suggesting that it may be mediated via an alternative pathway.
66. Kirkham FJ, deVeber GA, Chan A, et al.: Recurrent stroke: the role of prothrombic disorders [abstract]. Ann Neurol 2003, 54(Suppl 7):S110 (D3). An analysis of data on 565 patients pooled from centers in Canada, Germany, and the United Kingdom found a risk of recurrent stroke of 10% overall. Low protein C, protein S, and antithrombin levels; high anticardiolipin titers; and activated protein C resistance were all nonsignificantly associated with recurrent stroke.
67. Günther G, Junker R, Strater R, et al.: Childhood Stroke Study Group. Symptomatic ischemic stroke in full-term neonates: role of acquired and genetic prothrombic risk factors. Stroke 2000, 31:2437-2441.
68. Zenz W, Bodo Z, Plotho J, et al.: Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 1998, 80:763-766.
69. Hagstrom JN, Walter J, Bluebond-Langner R, et al.: Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998, 133:777-781.
70. Akar N, Akar E, Yilmaz E, et al.: Plasminogen activator inhibitor-1 4G/ 5G polymorphism in Turkish children with cerebral infarct and effect on factor V 1691 A mutation. J Child Neurol 2001, 16:294-295.
71. Ganesan V, McShane MA, Liesner R, et al.: Inherited prothrombic states and ischaemic stroke in childhood. J Neurol Neurosurg Psychiatry 1998, 65:508-511.
72. Bonduel M, Sciuccati G, Hepner M, et al.: Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003, 73:81-86. There was no evidence for an association of factor V Leiden or prothrombin G20210A with arterial stroke or sinovenous thrombosis in this Argentinian series, although 18% of patients had a prothrombic abnormality.
73. Kuhle S, Lane DA, Jochmanns K, et al.: Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Thromb Haemost 2001, 86:1007-1011.
74. Nowak-Gottl U, Strater R, Kosch A, et al.: The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group. Eur J Haematol 2001, 66:57-62.
75. Akar N, Duman T, Akar E, et al.: The alpha2 gene alleles of the platelet collagen receptor integrin alpha2 beta1 in Turkish children with cerebral infarct. Thromb Res 2001, 102:121-123.
76. Deda G, Icagasioglu D, Caksen H, et al.: Combined genetic defects in a child with ischemic stroke: case report. J Child Neurol 2002, 17:533-534.
77. Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001, 32:1257-1262.
78. Miller ST, Sleeper LA, Pegelow CH, et al.: Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83-89.
79. Taylor JG, Tang D, Foster CB, et al.: Patterns of low affinity immunoglobulin receptor polymorphisms in stroke and sickle cell disease. Am J Hematol 2002, 69:109-114. There was no evidence of an association between the common polymorphisms of the low-affinity immunoglobulin receptor and clinical stroke in this Jamaican population investigated mainly with CT or angiography rather than MRI.
80. Hoppe C, Cheng S, Grow M, et al.: A novel multilocus genotyping assay to identify genetic predictors of stroke in sickle cell anaemia. Br J Haematol 2001, 114:718-720.
81. Hoppe C, Klitz W, Noble J, et al.: Distinct HLA associations by stroke subtype in children with sickle cell anemia Blood 2003, 101:2865-2869. Different HLA types were associated with large and small vessel stroke, diagnosed on MRI, and with protection from stroke in these children with sickle cell disease.
82. Zou LP, Guo YH, Fang F, et al.: Evidence for human leukocyte antigen-related susceptibility in idiopathic childhood ischemic stroke. Eur Neurol 2002, 48:153-157. HLA-B51 was more common in children with idiopathic stroke than in control subjects, and the majority of those with HLA-B51 had stroke in the context of respiratory tract infection.
83. Kluger G, Hubmann M, Vogler L, et al.: Lack of association between childhood stroke after varicella and human leukocyte antigen (HLA)-B51. Eur J Paediatr Neurol 2001, 5:259-260.
84. Soriano SG, Cowan DB, Proctor MR, et al.: Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Neurosurgery 2002, 50:544-549. Children with moyamoya syndrome exhibited significantly elevated cerebrospinal fluid levels of soluble vascular cell adhesion molecule type 1, intercellular adhesion molecule type 1, and E-selectin compared with control subjects, although there was no association with Suzuki stage.
85. Inwald DP, Kirkham FJ, Peters MJ, et al.: Platelet and leukocyte activation in childhood sickle cell disease: association with nocturnal hypoxaemia. Br J Haematol 2000, 111:474-481.
86. Setty BN, Stuart MJ, Dampier C, Brodecki D, Allen JL: Hypoxaemia in sickle cell disease: biomarker modulation and relevance to pathophysiology. Lancet 2003, 362:1450-1455. Laboratory evidence is presented indicating that adhesion is more likely in hypoxemic patients.
87. Taylor JG, Tang DC, Savage S, et al.: Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 2002, 100:4303-4309.
88. Akar N, Akar E, Deda G, et al.: No association between Glu/Asp polymorphism of NOS3 gene and ischemic stroke. Neurology 2000, 8:460-461.
89. Meschia JF, Brott TG, Brown RD Jr, et al.: The Ischemic Stroke Genetics Study (ISGS) protocol. BMC Neurol 2003, 3:4. This study provides a rationale for a large study of polymorphisms for β-fibrinogen and platelet glycopratein Ia, Iba, and IIb/IIIa in adults with stroke, because associations have been positive in several studies. In addition, there is evidence for the involvement of fibrinogen in thrombosis and atherosclerosis, and the important therapeutic effect of antiplatelet agents suggests an important role for platelet adhesion. A useful list of candidate polymorphism association studies in adults is provided.